The 2026 Enbridge Tour Alberta for Cancer concluded in Strathmore this weekend with more than 2,300 cyclists taking part and a record haul of $12.5 million pledged for cancer research and patient services in Alberta.
Funds to flow into research, trials and supports
The Alberta Cancer Foundation will direct the money to leading-edge research, including clinical trials, and to patient support programs delivered across the province’s 17 cancer centres. Organizers said the contribution will strengthen local capacity for treatments and support services.
“This level of dedication is truly remarkable,” said Wendy Beauchesne, CEO of the Alberta Cancer Foundation, praising the riders, teams and sponsors whose efforts pushed the total to a new high.
Among the participants was Strathmore rider Heidi Panych, who spoke about how personal experience with cancer motivated her to join the ride. In recent years she faced her own diagnosis and treatment and returned to the event to share her story and support others affected by cancer.
Long-term partnerships and community momentum
The event’s momentum is closely linked to its title sponsor. Team Enbridge — formed by employees and their networks — reached another milestone: the team has now raised more than $10 million cumulatively since it began participating. Enbridge has been the Tour’s title sponsor since 2010.
- Participants: More than 2,300 cyclists
- Funds raised: $12.5 million for the Alberta Cancer Foundation
- Beneficiaries: Research, clinical trials, patient supports and care across 17 cancer centres
| Metric | Figure |
|---|---|
| Riders | 2,300+ |
| Amount raised | $12.5 million |
| Cancer centres served | 17 |
Funds raised through community events such as this are earmarked to expand clinical trial opportunities and patient supports that are not always covered by core health budgets. Organizers and the Alberta Cancer Foundation said donations enable faster adoption of promising treatments and provide wraparound supports for patients and families.
Event organisers credited the record outcome to sustained community participation, corporate sponsorship and the personal stories of those affected by cancer who mobilized friends, family and colleagues to fundraise and ride. The result underlines the continued role of community-driven philanthropy in supporting provincial cancer-care initiatives.
Riders, donors and volunteers will continue to be a visible part of fundraising and awareness efforts as the province seeks to broaden access to clinical trials and patient supports in the years ahead.
